Memantine can protect against inflammation-based cognitive decline in geriatric depression

Brain, Behavior, & Immunity - Health - Tập 9 - Trang 100167 - 2020
Kathleen Van Dyk1, Prabha Siddarth1, Maura Rossetti2, Linda M. Ercoli1, Michaela M. Milillo1, Helen Lavretsky1
1Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA
2UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

Tài liệu tham khảo

Bauer, 2019, Inflammation in psychiatric disorders: what comes first?, Ann. N. Y. Acad. Sci., 1437, 57, 10.1111/nyas.13712 Berg, 1988, Clinical dementia rating (CDR), Psychopharmacol. Bull., 24, 637 Bettcher, 2018, Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of alzheimer’s disease pathology and neuronal damage, J Alzheimers Dis, 62, 385, 10.3233/JAD-170602 Bhalla, 2009, Patterns of mild cognitive impairment after treatment of depression in the elderly, Am. J. Geriatr. Psychiatr., 17, 308, 10.1097/JGP.0b013e318190b8d8 Bhattacharyya, 2019, Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients, Transl. Psychiatry, 9, 173, 10.1038/s41398-019-0507-5 Cacabelos, 1999, The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer’s disease, Int. J. Geriatr. Psychiatr., 14, 3, 10.1002/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7 Charlton, 2014, White-matter tract integrity in late-life depression: associations with severity and cognition, Psychol. Med., 44, 1427, 10.1017/S0033291713001980 CJ, 1978 Conwell, 1998, Age differences in behaviors leading to completed suicide, Am. J. Geriatr. Psychiatr., 6, 122, 10.1097/00019442-199805000-00005 da Fonseca, 2014, The impact of microglial activation on blood-brain barrier in brain diseases, Front. Cell. Neurosci., 8, 362, 10.3389/fncel.2014.00362 Damsker, 2010, Th1 and Th17 cells: adversaries and collaborators, Ann. N. Y. Acad. Sci., 1183, 211, 10.1111/j.1749-6632.2009.05133.x Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297 Dantzer, 2014, Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?, J. Neural. Transm., 121, 925, 10.1007/s00702-014-1187-1 de la Monte, 2008, Alzheimer’s disease is type 3 diabetes-evidence reviewed, J Diabetes Sci Technol, 2, 1101, 10.1177/193229680800200619 Delis Kaplan, 2000 Elderkin-Thompson, 2012, Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults, Am. J. Geriatr. Psychiatr., 20, 753, 10.1097/JGP.0b013e31825d08d6 Eyre, 2017, Comparing the immune-genomic effects of vilazodone and paroxetine in late-life depression: a pilot study, Pharmacopsychiatry, 50, 256, 10.1055/s-0043-107033 Eyre, 2016, A meta-analysis of chemokines in major depression, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 68, 1, 10.1016/j.pnpbp.2016.02.006 Finneran, 2019, Neuroinflammation and fractalkine signaling in Alzheimer’s disease, J. Neuroinflammation, 16, 30, 10.1186/s12974-019-1412-9 Folstein, 1985, The meaning of cognitive impairment in the elderly, J. Am. Geriatr. Soc., 33, 228, 10.1111/j.1532-5415.1985.tb07109.x Folstein, 1975, Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 Franceschi, 2014, Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases, J Gerontol A Biol Sci Med Sci, 69, S4, 10.1093/gerona/glu057 Grzenda, 2020, Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression, Mol. Psychiatr., 10.1038/s41380-020-0752-2 Hair, 2010 Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Haroon, 2017, Inflammation, glutamate, and glia: a trio of trouble in mood disorders, Neuropsychopharmacology, 42, 193, 10.1038/npp.2016.199 Harvey, 2019, Domains of cognition and their assessment, Dialogues Clin. Neurosci., 21, 227, 10.31887/DCNS.2019.21.3/pharvey Heaton, 2004 Hudetz, 2009, Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery, Acta Anaesthesiol. Scand., 53, 864, 10.1111/j.1399-6576.2009.01978.x Hughes, 1982, A new clinical scale for the staging of dementia, Br. J. Psychiatr., 140, 566, 10.1192/bjp.140.6.566 Kanchanatawan, 2018, Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 80, 168, 10.1016/j.pnpbp.2017.06.031 Kohler, 2016, Inflammation in depression and the potential for anti-inflammatory treatment, Curr. Neuropharmacol., 14, 732, 10.2174/1570159X14666151208113700 Kuehn, 2020 Lai, 2017, Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies, J. Neurol. Neurosurg. Psychiatry, 88, 876, 10.1136/jnnp-2017-316201 Langa, 2014, The diagnosis and management of mild cognitive impairment: a clinical review, Jama, 312, 2551, 10.1001/jama.2014.13806 Lanza, 2020, On the conundrum of cognitive impairment due to depressive disorder in older patients, PloS One, 15, 10.1371/journal.pone.0231111 Lassale, 2019, Association of 10-year C-reactive protein trajectories with markers of healthy aging: findings from the English longitudinal study of aging, J Gerontol A Biol Sci Med Sci, 74, 195, 10.1093/gerona/gly028 Lavretsky, 2020, A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints, Am. J. Geriatr. Psychiatr., 28, 178, 10.1016/j.jagp.2019.08.011 Lavretsky, 1998, Relationship of age, age at onset, and sex to depression in older adults, Am. J. Geriatr. Psychiatr., 6, 248, 10.1097/00019442-199808000-00007 Lee, 2007, Persistent mild cognitive impairment in geriatric depression, Int. Psychogeriatr., 19, 125, 10.1017/S1041610206003607 Limatola, 2014, Modulating neurotoxicity through CX3CL1/CX3CR1 signaling, Front. Cell. Neurosci., 8, 229, 10.3389/fncel.2014.00229 Lindqvist, 2017, Oxidative stress, inflammation and treatment response in major depression, Psychoneuroendocrinology, 76, 197, 10.1016/j.psyneuen.2016.11.031 Lu, 2019, Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-alpha-induced inflammation in microglia cells, Int. Immunopharm., 67, 119, 10.1016/j.intimp.2018.12.011 Meyers, 1995 Miller, 2016, The role of inflammation in depression: from evolutionary imperative to modern treatment target, Nat. Rev. Immunol., 16, 22, 10.1038/nri.2015.5 Morimoto, 2013, Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment, Psychiatr. Clin., 36, 517 Ng, 2018, IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or alzheimer’s disease: systematic review and meta-analysis, Sci. Rep., 8, 12050, 10.1038/s41598-018-30487-6 Ownby, 2010, Neuroinflammation and cognitive aging, Curr. Psychiatr. Rep., 12, 39, 10.1007/s11920-009-0082-1 Pelton, 2016, Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study, Int. J. Geriatr. Psychiatr., 31, 648, 10.1002/gps.4375 Petersen, 2004, Mild cognitive impairment as a diagnostic entity, J. Intern. Med., 256, 183, 10.1111/j.1365-2796.2004.01388.x Proescholdt, 2001, Neuroprotection of S(+) ketamine isomer in global forebrain ischemia, Brain Res., 904, 245, 10.1016/S0006-8993(01)02465-9 Ramirez, 2010, Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis, J. Neurosci., 30, 9454, 10.1523/JNEUROSCI.5796-09.2010 Reitan, 1958, Validity of the Trail Making Test as an indicator of organic brain damage, Percept. Mot. Skills, 8, 271, 10.2466/pms.1958.8.3.271 Reynolds, 2006, Maintenance treatment of major depression in old age, N. Engl. J. Med., 354, 1130, 10.1056/NEJMoa052619 Rissin, 2010, Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations, Nat. Biotechnol., 28, 595, 10.1038/nbt.1641 Rogawski, 2003, The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease, CNS Drug Rev., 9, 275, 10.1111/j.1527-3458.2003.tb00254.x Rosales-Corral, 2015, Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress, Oxid Med Cell Longev, 2015, 10.1155/2015/985845 Rosenblat, 2014, Inflamed moods: a review of the interactions between inflammation and mood disorders, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 53, 23, 10.1016/j.pnpbp.2014.01.013 Rush, 2006, Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report, Am. J. Psychiatr., 163, 1905, 10.1176/ajp.2006.163.11.1905 Sas, 2009, Interferon-alpha causes neuronal dysfunction in encephalitis, J. Neurosci., 29, 3948, 10.1523/JNEUROSCI.5595-08.2009 Shen, 2010, ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer’s disease, J. Neurochem., 114, 1590, 10.1111/j.1471-4159.2010.06887.x Steffens, 2008, Separating mood disturbance from mild cognitive impairment in geriatric depression, Int. Rev. Psychiatr., 20, 374, 10.1080/09540260802094589 Strauss, 2006 Strawbridge, 2015, Inflammation and clinical response to treatment in depression: a meta-analysis, Eur. Neuropsychopharmacol, 25, 1532, 10.1016/j.euroneuro.2015.06.007 Sun, 2020, The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine, Brain Behav. Immun., 87, 404, 10.1016/j.bbi.2020.01.011 Takahashi, 2018, Memantine ameliorates depressive-like behaviors by regulating hippocampal cell proliferation and neuroprotection in olfactory bulbectomized mice, Neuropharmacology, 137, 141, 10.1016/j.neuropharm.2018.04.013 Turner, 2014, Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease, Biochim. Biophys. Acta, 1843, 2563, 10.1016/j.bbamcr.2014.05.014 Vega, 2016, Altered brain connectivity in early postmenopausal women with subjective cognitive impairment, Front. Neurosci., 10, 433, 10.3389/fnins.2016.00433 Wechsler, 2009 Wei, 2016, Contra-directional coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for memantine-induced anti-inflammation and anti-mitochondrial impairment, Mol. Neurobiol., 53, 5876, 10.1007/s12035-015-9477-7 Winblad, 2004, Mild cognitive impairment–beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment, J. Intern. Med., 256, 240, 10.1111/j.1365-2796.2004.01380.x Yang, 2019, Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review, J. Affect. Disord., 257, 640, 10.1016/j.jad.2019.07.045 Yang, 2015, C-reactive protein plays a marginal role in cognitive decline: a systematic review and meta-analysis, Int. J. Geriatr. Psychiatr., 30, 156, 10.1002/gps.4236 Zhang, 2007, Cytokines, inflammation, and pain, Int. Anesthesiol. Clin., 45, 27, 10.1097/AIA.0b013e318034194e Zwicker, 2018, Genetic disposition to inflammation and response to antidepressants in major depressive disorder, J. Psychiatr. Res., 105, 17, 10.1016/j.jpsychires.2018.08.011